Related references
Note: Only part of the references are listed.Long-term risk of subsequent cancer incidence among hereditary and nonhereditary retinoblastoma survivors
Sara J. Schonfeld et al.
BRITISH JOURNAL OF CANCER (2021)
Genomic signatures define three subtypes of EGFR-mutant stage II-III non-small-cell lung cancer with distinct adjuvant therapy outcomes
Si-Yang Liu et al.
NATURE COMMUNICATIONS (2021)
Combined TP53 and RB1 Loss Promotes Prostate Cancer Resistance to a Spectrum of Therapeutics and Confers Vulnerability to Replication Stress
Michael D. Nyquist et al.
CELL REPORTS (2020)
Lineage plasticity in cancer: a shared pathway of therapeutic resistance
Alvaro Quintanal-Villalonga et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Pan-cancer molecular analysis of the RB tumor suppressor pathway
Erik S. Knudsen et al.
COMMUNICATIONS BIOLOGY (2020)
A Code of Mono-phosphorylation Modulates the Function of RB
Ioannis Sanidas et al.
MOLECULAR CELL (2019)
Cyclin D-CDK4 relieves cooperative repression of proliferation and cell cycle gene expression by DREAM and RB
Amy E. Schade et al.
ONCOGENE (2019)
Retinoblastoma mutation predicts poor outcomes in advanced non small cell lung cancer
Priyanka Bhateja et al.
CANCER MEDICINE (2019)
Cyclin D-Cdk4,6 Drives Cell-Cycle Progression via the Retinoblastoma Protein's C-Terminal Helix
Benjamin R. Topacio et al.
MOLECULAR CELL (2019)
Genomic correlates of clinical outcome in advanced prostate cancer
Wassim Abida et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Pan-cancer Convergence to a Small-Cell Neuroendocrine Phenotype that Shares Susceptibilities with Hematological Malignancies
Nikolas G. Balanis et al.
CANCER CELL (2019)
Pan-cancer whole-genome analyses of metastatic solid tumours
Peter Priestley et al.
NATURE (2019)
Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy
Ferdinandos Skoulidis et al.
NATURE REVIEWS CANCER (2019)
Cell Cycle and Beyond: Exploiting New RB1 Controlled Mechanisms for Cancer Therapy
Erik S. Knudsen et al.
TRENDS IN CANCER (2019)
Clonal Evolution and Epithelial Plasticity in the Emergence of AR-Independent Prostate Carcinoma
Sara Laudato et al.
TRENDS IN CANCER (2019)
Differential impact of RB status on E2F1 reprogramming in human cancer
Christopher McNair et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Non-canonical functions of the RB protein in cancer
Frederick A. Dick et al.
NATURE REVIEWS CANCER (2018)
Genomic Landscape of Retinoblastoma in Rb -/- p130 -/- Mice Resembles Human Retinoblastoma
Irsan E. Kooi et al.
GENES CHROMOSOMES & CANCER (2017)
Ablating all three retinoblastoma family members in mouse lung leads to neuroendocrine tumor formation
Sara Lazaro et al.
ONCOTARGET (2017)
Rb family proteins enforce the homeostasis of quiescent hematopoietic stem cells by repressing Socs3 expression
Eunsun Kim et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Integrative clinical genomics of metastatic cancer
Dan R. Robinson et al.
NATURE (2017)
Evolution and clinical impact of co-occurring genetic alterations in advanced-stage EGFR-mutant lung cancers
Collin M. Blakely et al.
NATURE GENETICS (2017)
Conservation and divergence of C-terminal domain structure in the retinoblastoma protein family
Tyler J. Liban et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
SOX2 promotes lineage plasticity and antiandrogen resistance in TP53-and RB1-deficient prostate cancer
Ping Mu et al.
SCIENCE (2017)
Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance
Sheng Yu Ku et al.
SCIENCE (2017)
Androgen Receptor Pathway-Independent Prostate Cancer Is Sustained through FGF Signaling
Eric G. Bluemn et al.
CANCER CELL (2017)
SUMOylation of Rb enhances its binding with CDK2 and phosphorylation at early G1 phase
Fengxi Meng et al.
CELL CYCLE (2016)
RB1: a prototype tumor suppressor and an enigma
Nicholas J. Dyson
GENES & DEVELOPMENT (2016)
Coexistence of p16/CDKN2A homozygous deletions and activating EGFR mutations in lung adenocarcinoma patients signifies a poor response to EGFR-TKIs
Juhong Jiang et al.
LUNG CANCER (2016)
The N-Terminal Phosphorylation of RB by p38 Bypasses Its Inactivation by CDKs and Prevents Proliferation in Cancer Cells
Albert Gubern et al.
MOLECULAR CELL (2016)
Inhibition of Pluripotency Networks by the Rb Tumor Suppressor Restricts Reprogramming and Tumorigenesis
Michael S. Kareta et al.
CELL STEM CELL (2015)
Structural mechanisms of DREAM complex assembly and regulation
Keelan Z. Guiley et al.
GENES & DEVELOPMENT (2015)
RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer
Matthew J. Niederst et al.
NATURE COMMUNICATIONS (2015)
Transcriptional control of stem cell fate by E2Fs and pocket proteins
Lisa M. Julian et al.
FRONTIERS IN GENETICS (2015)
PhosphoSitePlus, 2014: mutations, PTMs and recalibrations
Peter V. Hornbeck et al.
NUCLEIC ACIDS RESEARCH (2015)
Transcriptional regulation of Sox2 by the retinoblastoma family of pocket proteins
Jessica M. Vilas et al.
ONCOTARGET (2015)
Distinct and Site-Specific Phosphorylation of the Retinoblastoma Protein at Serine 612 in Differentiated Cells
Takayuki Hattori et al.
PLOS ONE (2014)
A comparative study of Whi5 and retinoblastoma proteins: from sequence and structure analysis to intracellular networks
Md Mehedi Hasan et al.
FRONTIERS IN PHYSIOLOGY (2014)
The retinoblastoma protein induces apoptosis directly at the mitochondria
Keren I. Hilgendorf et al.
GENES & DEVELOPMENT (2013)
Emerging roles of RB family: New defense mechanisms against tumor progression
Paola Indovina et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2013)
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao et al.
SCIENCE SIGNALING (2013)
p27Kip1 Directly Represses Sox2 during Embryonic Stem Cell Differentiation
Han Li et al.
CELL STEM CELL (2012)
Structures of inactive retinoblastoma protein reveal multiple mechanisms for cell cycle control
Jason R. Burke et al.
GENES & DEVELOPMENT (2012)
A novel retinoblastoma therapy from genomic and epigenetic analyses
Jinghui Zhang et al.
NATURE (2012)
The RB family is required for the self-renewal and survival of human embryonic stem cells
Jamie F. Conklin et al.
NATURE COMMUNICATIONS (2012)
A Novel Tumor suppressor network in squamous malignancies
Clotilde Costa et al.
SCIENTIFIC REPORTS (2012)
RB1 Methylation by SMYD2 Enhances Cell Cycle Progression through an Increase of RB1 Phosphorylation
Hyun-Soo Cho et al.
NEOPLASIA (2012)
Cell of Origin of Small Cell Lung Cancer: Inactivation of Trp53 and Rb1 in Distinct Cell Types of Adult Mouse Lung
Kate D. Sutherland et al.
CANCER CELL (2011)
Newly identified aspects of tumor suppression by RB
Patrick Viatour et al.
DISEASE MODELS & MECHANISMS (2011)
Interplay between lysine methylation and Cdk phosphorylation in growth control by the retinoblastoma protein
Simon M. Carr et al.
EMBO JOURNAL (2011)
Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors
Lecia V. Sequist et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Dissecting the Unique Role of the Retinoblastoma Tumor Suppressor during Cellular Senescence
Agustin Chicas et al.
CANCER CELL (2010)
Rb regulates fate choice and lineage commitment in vivo
Eliezer Calo et al.
NATURE (2010)
An overlapping kinase and phosphatase docking site regulates activity of the retinoblastoma protein
Alexander Hirschi et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2010)
Lysine methylation regulates the pRb tumour suppressor protein
S. Munro et al.
ONCOGENE (2010)
p107 in the public eye: an Rb understudy and more
Stacey E. Wirt et al.
CELL DIVISION (2010)
Retinoblastoma Family Proteins Have Distinct Functions in Pulmonary Epithelial Cells In vivo Critical for Suppressing Cell Growth and Tumorigenesis
David S. Simpson et al.
CANCER RESEARCH (2009)
Retinoblastoma Protein (pRb), but Not p107 or p130, Is Required for Maintenance of Enterocyte Quiescence and Differentiation in Small Intestine
Jun Guo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Aurora B Kinase Regulates the Postmitotic Endoreduplication Checkpoint via Phosphorylation of the Retinoblastoma Protein at Serine 780
Jayasree S. Nair et al.
MOLECULAR BIOLOGY OF THE CELL (2009)
The retinoblastoma gene Rb and its family member p130 suppress lung adenocarcinoma induced by oncogenic K-Ras
V. M. Ho et al.
ONCOGENE (2009)
Hematopoietic Stem Cell Quiescence Is Maintained by Compound Contributions of the Retinoblastoma Gene Family
Patrick Viatour et al.
CELL STEM CELL (2008)
Gene profiling approaches help to define the specific functions of retinoblastoma family in epidermis
M. Fernanda Lara et al.
MOLECULAR CARCINOGENESIS (2008)
p107 acts as a tumor suppressor in pRb-deficient epidermis
M. Fernanda Lara et al.
MOLECULAR CARCINOGENESIS (2008)
Metastatic osteosarcoma induced by inactivation of Rb and p53 in the osteoblast lineage
Seth D. Berman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The retinoblastoma tumor suppressor is a critical intrinsic regulator for hematopoietic stem and progenitor cells under stress
Deidre Daria et al.
BLOOD (2008)
Mammalian Mip/LIN-9 interacts with either the p107, p130/E2F4 repressor complex or B-Myb in a cell cycle-phase-dependent context distinct from the Drosophila dREAM complex
M. Pilkinton et al.
ONCOGENE (2007)
Crystal structure of the retinoblastoma protein N domain provides insight into tumor suppression, ligand interaction, and holoprotein architecture
Markus Hassler et al.
MOLECULAR CELL (2007)
Structure of the retinoblastoma protein bound to adenovirus E1A reveals the molecular basis for viral oncoprotein inactivation of a tumor suppressor
Xin Liu et al.
GENES & DEVELOPMENT (2007)
Evolutionarily conserved multisubunit RBL2/p130 and E2F4 protein complex represses human cell cycle-dependent genes in quiescence
Larisa Litovchick et al.
MOLECULAR CELL (2007)
Phosphorylation of pRB at Ser612 by Chk1/2 leads to a complex between pRB and E2F-1 after DNA damage
Yasumichi Inoue et al.
EMBO JOURNAL (2007)
The retinoblastoma tumor-suppressor gene, the exception that proves the rule
D. W. Goodrich
ONCOGENE (2006)
p14ARF promotes RB accumulation through inhibition of its Tip60-dependent acetylation
C. Leduc et al.
ONCOGENE (2006)
Lung adenocarcinomas induced in mice by mutant EGF receptors found in human lung cancers respond to a tyrosine kinase inhibitor or to down-regulation of the receptors
Katerina Politi et al.
GENES & DEVELOPMENT (2006)
The impact of human EGFR kinase domain mutations on lung tumorigenesis and in vivo sensitivity to EGFR-targeted therapies
Hongbin Ji et al.
CANCER CELL (2006)
Compensation by tumor suppressor genes during retinal development in mice and humans
Stacy L. Donovan et al.
BMC BIOLOGY (2006)
Mdm2-mediated pRB downregulation is involved in carcinogenesis in a p53-independent manner
S Miwa et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
DNA-damage-responsive acetylation of pRb regulates binding to E2F-1
D Markham et al.
EMBO REPORTS (2006)
Structure of the RbC-terminal domain bound to E2F1-DP1: A mechanism for phosphorylation-induced E2F release
SM Rubin et al.
CELL (2005)
Viral oncoproteins E1A and E7 and cellular LxCxE proteins repress SUMO modification of the retinoblastoma tumor suppressor
A Ledl et al.
ONCOGENE (2005)
The signals and pathways activating cellular senescence
I Ben-Porath et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2005)
Acetylation regulates the differentiation-specific functions of the retinoblastoma protein
DX Nguyen et al.
EMBO JOURNAL (2004)
Cell type-specific effects of Rb deletion in the murine retina
D MacPherson et al.
GENES & DEVELOPMENT (2004)
Tissue-specific tumor suppressor activity of retinoblastoma gene homologs p107 and p130
JH Dannenberg et al.
GENES & DEVELOPMENT (2004)
Unique and overlapping functions of pRb and p107 in the control of proliferation and differentiation in epidermis
S Ruiz et al.
DEVELOPMENT (2004)
Cell-specific effects of RB or RB/p107 loss on retinal development implicate an intrinsically death-resistant cell-of-origin in retinoblastoma
D Chen et al.
CANCER CELL (2004)
Apoptotic and mitogenic stimuli inactivate Rb by differential utilization of p38 and cyclin-dependent kinases
N Nath et al.
ONCOGENE (2003)
Crystal structure of the retinoblastoma tumor suppressor protein bound to E2F and the molecular basis of its regulation
B Xiao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Structural basis for the recognition of the E2F transactivation domain by the retinoblastoma tumor suppressor
C Lee et al.
GENES & DEVELOPMENT (2002)
Activation of the Rb/E2F1 pathway by the nonproliferative p38 MAPK during fAs (APO1/CD95)-mediated neuronal apoptosis
ST Hou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The pRb-related protein p130 is regulated by phosphorylation-dependent proteolysis via the protein-ubiquitin ligase SCFSkp2
D Tedesco et al.
GENES & DEVELOPMENT (2002)
Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras
EL Jackson et al.
GENES & DEVELOPMENT (2001)
Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes
GH Fisher et al.
GENES & DEVELOPMENT (2001)
Acetylation control of the retinoblastoma tumour-suppressor protein
HM Chan et al.
NATURE CELL BIOLOGY (2001)
Phosphorylation-dependent and -independent functions of p130 cooperate to evoke a sustained G1 block
K Hansen et al.
EMBO JOURNAL (2001)
Structural basis for the inactivation of retinoblastoma tumor suppressor by SV40 large T antigen
HY Kim et al.
EMBO JOURNAL (2001)
Share Paper
